Lower adropin expression is associated with oxidative stress and NAFLD severity [32]; the antioxidant properties of adropin in NASH are mediated by the activation of NRF2 (nuclear factor erythroid 2–related factor 2) signaling, leading to liver protection against injury [54]. Here, ENHO is linked to metabolic dysfunction-associated steatotic liver disease.